COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 9 of 9 for:    Otelixizumab

Repeat Dose Subcutaneous Rhumatoid Arthritis Efficacy Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01101555
Recruitment Status : Completed
First Posted : April 12, 2010
Last Update Posted : June 12, 2017
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 16, 2011
Actual Study Completion Date : November 29, 2012